Italia markets closed

BMY Dec 2024 48.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,08000,0000 (0,00%)
Alla chiusura: 01:27PM EDT
Schermo intero
Chiusura precedente1,0800
Aperto1,0800
Denaro0,7400
Domanda1,1200
Prezzo d'esercizio48,00
Scadenza2024-12-20
Min-Max giorno1,0800 - 1,0800
Contratto - Min-MaxN/D
Volume2
Open Interest973
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri